蒙特利尔认知评估与画钟试验识别孤立性快速眼动睡眠行为障碍中的轻度认知损害并预测痴呆
本研究回顾性纳入64例多导睡眠图确诊的孤立性快速眼动睡眠行为障碍(iRBD)患者及32名对照,评估蒙特利尔认知评估(MoCA)和画钟试验(CDT)识别轻度认知损害(MCI)及预测路易体痴呆(DLB)的效能。MoCA总分的某些界值可较好区分后续发展为DLB的患者与对照,而CDT未找到可接受的界值。
要点
- 在iRBD中,MoCA总分≤25/30区分后续DLB与对照的敏感度为100%、特异度78%。
- MoCA延迟回忆≤3/5区分后续DLB的敏感度为83%、特异度78%。
- CDT在iRBD中未找到可接受的界值以识别MCI或预测DLB。
核心结论
- 在iRBD中,MoCA具有足够的心理测量学特性以识别DLB风险最高的患者并筛查MCI,而CDT则不能。
研究设计与样本
- 回顾性选择并随访2006年至2021年间睡眠门诊收治的64例多导睡眠图确诊的iRBD患者,其中32例伴MCI、32例不伴MCI,另纳入32名对照,所有参与者接受神经系统评估和神经心理学评估以诊断MCI,并完成MoCA和CDT。
- 53例患者完成随访,平均随访5.10±2.64年,其中6例发展为DLB、16例发展为帕金森病;另独立招募并随访10例后来发展为DLB的iRBD患者作为独立队列。
主要发现
- 区分后续发展为DLB的患者与对照的最佳界值为MoCA总分≤25/30,敏感度100%(95%CI 61%-100%)、特异度78%(61%-89%)、AUC=0.888。
- 区分后续发展为DLB的患者与对照的MoCA延迟回忆≤3/5界值,敏感度83%(44%-97%)、特异度78%(61%-89%)、AUC=0.875;这两个界值在独立队列中检测DLB风险患者的敏感度均为90%(60%-98%)。
- 区分MCI患者与对照的最佳界值为MoCA总分≤25/30(敏感度72%[55%-84%]、特异度78%[61%-89%]、AUC=0.803)和MoCA延迟回忆≤2/5(敏感度63%[45%-77%]、特异度94%[80%-98%]、AUC=0.843)。
- CDT未找到可接受的最佳界值。
关键数值与推荐
- MoCA总分≤25/30区分后续DLB与对照:敏感度100%(95%CI 61%-100%),特异度78%(61%-89%),AUC=0.888。
- MoCA延迟回忆≤3/5区分后续DLB与对照:敏感度83%(44%-97%),特异度78%(61%-89%),AUC=0.875。
- MoCA总分≤25/30区分MCI与对照:敏感度72%(55%-84%),特异度78%(61%-89%),AUC=0.803。
- MoCA延迟回忆≤2/5区分MCI与对照:敏感度63%(45%-77%),特异度94%(80%-98%),AUC=0.843。
- CDT未找到可接受的最佳界值。
临床怎么用
- 作者认为,在iRBD中MoCA可用于识别DLB风险最高的患者并筛查MCI,而CDT不适用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Patients with isolated/idiopathic REM sleep behavior disorder (iRBD) are at high risk for developing mild cognitive impairment (MCI) and dementia with Lewy bodies (DLB). However, there is a lack of scientific knowledge regarding the accuracy of cognitive screening tools to identify these conditions in iRBD. This study aimed to determine in iRBD the psychometrics of 2 screening tests to discriminate patients with MCI and those at risk of DLB. METHODS: We retrospectively selected and followed 64 patients with polysomnography-confirmed iRBD seen in sleep clinic between 2006 and 2021, 32 with MCI (mean age 68.44 years, 72% men), 32 without MCI (67.78 years, 66% men), and 32 controls (69.84 years, 47% men). Participants underwent a neurologic evaluation and neuropsychological assessment for MCI diagnosis. They also completed the Montreal Cognitive Assessment (MoCA) and Clock Drawing Test (CDT). Fifty-three patients were followed (mean of 5.10 ± 2.64 years); 6 developed DLB, and 16 developed Parkinson disease. An independent cohort of 10 patients with iRBD who later developed DLB was also recruited and followed. Receiver operating characteristic curves with area under the curve (AUC) were performed assessing the discriminant value of the MoCA and CDT. RESULTS: The cut-off values that best differentiated patients who developed DLB from controls were on the MoCA total score (≤25/30 with 100% [95% CI 61%-100%] sensitivity and 78% [61%-89%] specificity, AUC = 0.888) and delayed recall (≤3/5 with 83% [44%-97%] sensitivity and 78% [61%-89%] specificity, AUC = 0.875). Both values yielded a sensitivity of 90% (60%-98%) to detect patients at risk of DLB in the independent cohort. Cutoffs that best discriminated patients with MCI from controls were: ≤25/30 (MoCA total score) with 72% [55%-84%] sensitivity, 78% [61%-89%] specificity, AUC = 0.803 and ≤2/5 (MoCA delayed recall) with 63% [45%-77%] sensitivity, 94% [80%-98%] specificity, AUC = 0.843. No acceptable optimal values were found for the CDT. DISCUSSION: In iRBD, the MoCA demonstrates adequate psychometric properties to identify patients most at risk of developing DLB and to screen for MCI, whereas the CDT does not. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that the MoCA, but not the CDT, is useful in screening patients with iRBD for the risk of developing DLB.
引用
- Cogné É, Postuma RB, Chasles MJ, et al. Montreal Cognitive Assessment and the Clock Drawing Test to Identify MCI and Predict Dementia in Isolated REM Sleep Behavior Disorder. Neurology. 2024. PMID: 38271662. doi:10.1212/WNL.0000000000208020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。